Phase III Randomized COMMODORE 1 Trial: 2-Year Safety and Efficacy of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Switched from Eculizumab

被引：0

作者：

Scheinberg, Phillip ^{[1
]}

Cle, Diego Villa ^{[2
]}

Devalet, Berangere ^{[3
]}

Giai, Valentina ^{[4
]}

Lekue, Cristina Barrenetxea ^{[5
]}

Lin, Hsuan-Yu ^{[6
]}

Nagy, Zsolt ^{[7
]}

Nishimura, Jun-ichi ^{[8
]}

Panse, Jens ^{[9
,10
]}

Piekarska, Agnieszka ^{[11
]}

Schubert, Joerg ^{[12
]}

Sunami, Kazutaka ^{[13
]}

Yenerel, Mustafa ^{[14
]}

Appius, Anita ^{[15
]}

Gentile, Brittany ^{[16
]}

Iwase, Shino ^{[15
]}

Patel, Himika ^{[17
]}

Sreckovic, Sasha ^{[18
]}

Kulasekararaj, Austin G. ^{[19
,20
,21
,22
]}

机构：

[1] Hosp Beneficencia Portuguesa, Sao Paulo, Brazil

[2] Univ Sao Paulo, Ribeirao Preto Sch Med, Ribeirao Preto, Brazil

[3] Univ Catholique Louvain UCLouvain, CHU UCL Namur, Dept Hematol, Yvoir, Belgium

[4] AOU Citta Salute & Sci Torino, Hematol, Turin, Italy

[5] Hosp Univ Basurto, Bilbao, Spain

[6] Changhua Christian Hosp, Dept Internal Med, Div Hematol Oncol, Changhua, Taiwan

[7] Semmelweis Univ, Dept Internal Med & Hematol, Budapest, Hungary

[8] Osaka Univ, Grad Sch Med, Osaka, Japan

[9] Univ Hosp RWTH Aachen, Dept Oncol Hemostaseol & Stem Cell Transplantat, Aachen, Germany

[10] Univ Hosp RWTH Aachen, Dept Oncol Hemostaseol & Stem Cell Transplantat, Aachen, Germany

[11] Med Univ Gdansk, Dept Hematol & Transplantol, Gdansk, Poland

[12] Elblandklinikum Riesa, Riesa, Germany

[13] NHO Okayama Med Ctr, Dept Hematol, Okayama, Japan

[14] Istanbul Univ, Istanbul, Turkiye

[15] F Hoffmann La Roche Ltd, Basel, Switzerland

[16] Genentech Inc, South San Francisco, CA USA

[17] Canaudit Inc, Simi Valley, CA 93063 USA

[18] Genentech Inc, South San Francisco, CA USA

[19] Kings Coll Hosp London, NIHR Wellcome Kings Clin Res Facil, NHS Fdn Trust, London, England

[20] Kings Coll London, London, England

[21] Kings Coll London, Natl Inst Hlth & Care Res, London, England

[22] Wellcome Kings Res Facil, London, England

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-200745

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1313 / 1315

页数：3

共 50 条

[21] A phase 2, randomized trial evaluating the safety and efficacy of Pozelimab and Cemdisiran in patients with paroxysmal nocturnal hemoglobinuria
Jang, Jun-Ho
Wong, Raymond
Pavani, Rodrigo
Aurand, Lisa
Nguyen, Quang P.
Perlee, Lorah
Souttou, Amal
Weyne, Jonathan
Kelly, Richard J.
IMMUNOBIOLOGY, 2023, 228 (05) : 5 - 5
[22] A Phase 2, Randomized Trial Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran in Patients with Paroxysmal Nocturnal Hemoglobinuria
Jang, Jun Ho
Wong, Raymond
Pavani, Rodrigo
Aurand, Lisa
Dain, Bradley
Perlee, Lorah
Souttou, Amal
Weyne, Jonathan
Kelly, Richard
BLOOD, 2022, 140 : 8172 - 8173
[23] RESULTS OF THE PEGASUS PHASE III TRIAL FOR THE COMPARISON OF PEGCETACOPLAN WITH ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Jarque, Isidro
Hillmen, Peter
Szer, Jeff
Weitz, Ilene
Roeth, Alexander
Hoechsmann, Britta
Panse, Jens
Usuki, Kensuke
Griffin, Morag
Kiladjian, Jean-Jacques
De Castro, Carlos
Nishimori, Hisakazu
Tan, Lisa
Hamdani, Mohamed
Deschatelets, Pascal
Francois, Cedric
Grossi, Federico
Risitano, Antonio
Peffault, de latour Regis
HAEMATOLOGICA, 2020, 105 : 110 - 110
[24] Eculizumab treatment for Chinese patients with hemolytic paroxysmal nocturnal hemoglobinuria (PNH): efficacy and safety - a single-center study
Wang, Leyu
Liu, Ziwei
Yang, Chen
Chen, Miao
Han, Bing
HEMATOLOGY, 2025, 30 (01)
[25] One-year efficacy and safety from a phase 3 trial of ravulizumab in adult patients with paroxysmal nocturnal hemoglobinuria receiving prior eculizumab treatment
Kulasekararaj, A.
Mitchell, L.
Hill, A.
Langemeijer, S.
Wells, R.
Gonzalez Fernandez, F. A.
Gaya, A.
Gutierrez, O.
Piatek, C.
Usuki, K.
Bosi, A.
Brodsky, R.
Ogawa, M.
Yu, J.
Ortiz, S.
Roeth, A.
Lee, J. W.
de la Tour, R. Peffault
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 138 - 139
[26] One-year efficacy and safety from a phase 3 trial of ravulizumab in adult patients with paroxysmal nocturnal hemoglobinuria receiving prior eculizumab treatment
Roeth, A.
Kulasekararaj, A. G.
Hill, A.
Langemeijer, S.
Wells, R.
Gonzalez Fernandez, F. A.
Gaya, A.
Ojeda Gutierrez, E.
Piatek, C. I.
Mitchell, L.
Usuki, K.
Bosi, A.
Brodsky, R.
Ogawa, M.
Yu, J.
Ortiz, S.
Lee, J. W.
de la Tour, Peffault R.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 173 - 174
[27] One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Prior Eculizumab Treatment
Kulasekararaj, Austin
Hill, Anita
Langemeijer, Saskia
Wells, Richard A.
Gonzalez-Fernandez, F. Ataulfo
Gaya, Anna
Gutierrez, Emilio Ojeda
Piatek, Caroline I.
Mitchell, Lindsay D.
Usuki, Kensuke
Bosi, Alberto
Brodsky, Robert A.
Ogawa, Masayo
Yu, Ji
Ortiz, Stephan
Roth, Alexander
Lee, Jong-Wook
de Latour, Regis Peffault
BLOOD, 2019, 134
[28] One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab
Kulasekararaj, Austin G.
Hill, Anita
Langemeijer, Saskia
Wells, Richard
Gonzalez Fernandez, F. Ataulfo
Gaya, Anna
Ojeda Gutierrez, Emilio
Piatek, Caroline I.
Mitchell, Lindsay
Usuki, Kensuke
Bosi, Alberto
Brodsky, Robert A.
Ogawa, Masayo
Yu, Ji
Ortiz, Stephan
Roth, Alexander
Lee, Jong Wook
Peffault de Latour, Regis
EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (03) : 389 - 397
[29] Safety and efficacy of theterminal complement inhibitor eculizumab in patients with paroxysmal nocturnal hemoglobinuria: Shepherd phase III clinical study results
Schrezenmeier, H.
Luzzatto, L.
Rotoli, B.
Young, N. S.
Schubert, J.
Urbano-Ispizua, A.
Coyle, L.
DeCastro, C.
Fu, C. L.
Maciejewski, J. P.
Kroon, H. A.
Rother, R. P.
Hillmen, P.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 137 - 137
[30] Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
Yuzuru Kanakura
Kazuma Ohyashiki
Tsutomu Shichishima
Shinichiro Okamoto
Kiyoshi Ando
Haruhiko Ninomiya
Tatsuya Kawaguchi
Shinji Nakao
Hideki Nakakuma
Jun-ichi Nishimura
Taroh Kinoshita
Camille L. Bedrosian
Marye Ellen Valentine
Gus Khursigara
Keiya Ozawa
Mitsuhiro Omine
International Journal of Hematology, 2011, 93 : 36 - 46

← 1 2 3 4 5 →